Dale Q Rice Investment Management Ltd bought a new position in shares of Oracle Corporation (NYSE:ORCL - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 1,510 shares of the enterprise software provider's stock, valued at approximately $211,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of Oracle in the 4th quarter valued at about $2,216,314,000. Raymond James Financial Inc. bought a new stake in Oracle in the fourth quarter valued at approximately $930,095,000. GAMMA Investing LLC raised its stake in Oracle by 15,012.3% in the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock valued at $664,810,000 after buying an additional 4,723,631 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Oracle by 20.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock valued at $2,303,858,000 after buying an additional 2,350,448 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Oracle by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock worth $26,231,127,000 after acquiring an additional 2,296,069 shares during the period. 42.44% of the stock is owned by institutional investors.
Oracle Trading Down 2.8%
Shares of ORCL opened at $205.06 on Friday. The company has a debt-to-equity ratio of 4.07, a quick ratio of 1.02 and a current ratio of 0.75. Oracle Corporation has a 52-week low of $118.86 and a 52-week high of $216.60. The firm has a market cap of $573.53 billion, a price-to-earnings ratio of 47.25, a PEG ratio of 3.16 and a beta of 1.32. The business's fifty day moving average is $160.39 and its 200-day moving average is $161.52.
Oracle (NYSE:ORCL - Get Free Report) last released its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.06. The business had revenue of $15.90 billion for the quarter, compared to analyst estimates of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. Oracle's revenue was up 11.3% compared to the same quarter last year. During the same period last year, the firm posted $1.63 earnings per share. Equities analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.
Oracle Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 24th. Investors of record on Thursday, July 10th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, July 10th. Oracle's dividend payout ratio is 46.08%.
Insider Activity at Oracle
In other news, Director Naomi O. Seligman sold 2,000 shares of Oracle stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total transaction of $291,620.00. Following the sale, the director now directly owns 34,630 shares of the company's stock, valued at approximately $5,049,400.30. This trade represents a 5.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Leon E. Panetta sold 5,000 shares of Oracle stock in a transaction that occurred on Friday, April 11th. The stock was sold at an average price of $129.77, for a total transaction of $648,850.00. Following the sale, the director now owns 58,090 shares in the company, valued at approximately $7,538,339.30. This represents a 7.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 442,366 shares of company stock valued at $83,395,223 in the last quarter. Insiders own 42.20% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on ORCL shares. DA Davidson increased their price target on Oracle from $140.00 to $170.00 and gave the company a "neutral" rating in a research note on Thursday, June 12th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $240.00 price objective (up from $200.00) on shares of Oracle in a research report on Thursday, June 12th. Roth Capital reaffirmed a "hold" rating on shares of Oracle in a report on Wednesday. Royal Bank Of Canada upped their price target on shares of Oracle from $145.00 to $195.00 and gave the company a "sector perform" rating in a research note on Thursday, June 12th. Finally, CIBC restated a "buy" rating on shares of Oracle in a research report on Monday, June 9th. Eleven research analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $196.74.
Check Out Our Latest Research Report on ORCL
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report